C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/04/2004	US20040220386 Light chain of botulinum toxin having structurally modified terminal ends which confers enhanced half-life and biological activity for use in prevention and treatment of neuromuscular and pain disorders; cosmetics
11/04/2004	US20040220384 Novel ligand and dna thereof
11/04/2004	US20040220383 Methods and materials relating to semaphorin-like polynucleotides
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220132 Treatment of neurodegenerative disease through intracranial delivery of siRNA
11/04/2004	US20040220108 Neo-tryptophan
11/04/2004	US20040220107 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
11/04/2004	US20040220106 Modified vitamin K-dependent polypeptides
11/04/2004	US20040220105 glucagon-like peptide in gek form; antidiabetic agents
11/04/2004	US20040220099 Polypeptides selectively expressed in fat tissue and methods for use thereof
11/04/2004	US20040220098 Inhibin compositions and methods of enhancing fertility and growth
11/04/2004	US20040220094 Inverse agonist and agonist peptides that stimulate/inhibit hair growth
11/04/2004	US20040220093 Bacteriocins and novel bacterial strains
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040220088 Multiple domain glycoprotein hormones and methods of using
11/04/2004	US20040220086 contacting with protein which binds to cells in diseased tissue; antitumor agents
11/04/2004	US20040220085 Compositions for nucleic acid delivery
11/04/2004	US20040220076 Prevention of recurrent viral disease
11/04/2004	US20040219677 Synthetic genes and bacterial plasmids devoid of cpg
11/04/2004	US20040219675 Nucleic acid molecules from rice encoding proteins for abiotic stress tolerance, enhanced yeild, disease resistance and altered nutritional quality and uses thereof
11/04/2004	US20040219655 Nanoscale particles synthesized within an assembled virion
11/04/2004	US20040219653 Crystalline protein associated with fatty acid sequestration for use in designing drugs for use in treatment of diabetes; enzyme inhibitors
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219642 Using expression vector comprising nucleotide sequences coding interferon-specific transcriptional regulators and interferon receptors to transform cells and intensify expression of interferon; antiviral agents; antitumor agents
11/04/2004	US20040219641 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219639 Immunogenic fusion polypeptide comprising lytic epitopes for use in developing vaccine for prevention of mastitis in dairy cattle; veterinary medicine; immunotherapy
11/04/2004	US20040219637 Soluble recombinant botulinum toxins having a C-terminal portion of a heavy chain, a N-terminal portion of a heavy chain and a light chain
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	US20040219630 Production of functional polypeptides originating from silk protein and use thereof
11/04/2004	US20040219619 Methods of identifying compounds that alter toxin persistence and/or protease activity
11/04/2004	US20040219615 Antibody specific for a RAP-2 (RIP associated protein-2)of given sequence; mediating intracellular activity by introducing into cell DNA sequence encoding polypeptide in the form of a vector
11/04/2004	US20040219614 Produced from a hybridoma prepared by fusing a mouse spleen and myeloma cell; detecting tumors; kits
11/04/2004	US20040219598 Immunoglobulin which recognizes multiple antigenic peptides (MAP) for use in the diagnosis and differentiation between glandular and bone disorders
11/04/2004	US20040219597 Using cytokeratin marker peptides as diagnostic, prognostic and treatment tools for inflammations and/or infections in animals or humans; sepsis prevention; veterinary medicine
11/04/2004	US20040219591 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219585 Comprises nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, treatment and prevention of infection; antisense bactericidal agent; microbiocides; immunoassy
11/04/2004	US20040219582 Diagnosing cell proliferative disorders via presence of restriction fragment length polymorphism in fibroblast growth factor (FGF-3) gene
11/04/2004	US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004	US20040219554 Dna binding protein
11/04/2004	US20040219551 Comprises nucleotide sequences coding epithelial stromal interaction 1 (EPSTI-1) protein for use in tumor diagnosis and identifying modulators for treatment of cell prolifefrative and viral disorders
11/04/2004	US20040219542 Identifying modulators of polyimmunoglubulin receptor (pIgR) and transfer of molecules from one surface of cell to another; endocytosis/exocytosis/transcytosis and enhanced drug delivery
11/04/2004	US20040219528 Novel therapeutic targets in cancer
11/04/2004	US20040219521 Nucleotide sequences for use as tools in disease diagnostics, forensics, gene mapping, mutation identification and to assess biodiversity
11/04/2004	US20040219514 Caml-binding peptides
11/04/2004	US20040219225 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219170 Viruses encoding mutant membrane protein
11/04/2004	US20040219166 EIA vaccine and diagnostic
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219164 Advanced antigen presentation platform
11/04/2004	US20040219162 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
11/04/2004	US20040219161 Include recombinant expression constructs containing nucleic acids encoding target cell surface receptor antigen and one or more immune response altering molecules, or the expressed products themselves
11/04/2004	US20040219159 Immunogenic composition of mycobacteria from modified protein; heat shock proteins
11/04/2004	US20040219154 Monoclonal antibodies directed against hepatitis b viruses
11/04/2004	US20040219151 Tetraspan protein and uses thereof
11/04/2004	US20040219150 Uses of mammalian cytokine; related reagents
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219147 administering an anti-inflammatory compound, especially an antibody to a complement component or an NSAID, to a subject receiving a stent in connection with percutaneous transluminal coronary angioplasty.
11/04/2004	US20040219146 Prevention and treatment of amyloidogenic disease
11/04/2004	US20040219139 isolated, enriched or purified ALK-7 polypeptide.
11/04/2004	US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004	US20040219104 Methods for treatment of tumors
11/04/2004	US20040219102 Compositions for drug delivery
11/04/2004	US20040219101 Human vascular endothelial or epidermal growth factor and radiolabeled human transferrin; multitargeting, antimetastasis
11/04/2004	US20040219100 Human epidermal growth factor and radiolabeled human transferrin conjugate; targeting tumor cells and endothelial cells of tumor vasculature
11/04/2004	US20040219099 Using human vascular endothelial growth factor and radiolabeled human transferrin conjugate; targeting both tumor cells and endothelial cells of tumor vasculature; inhibiting angiogenesis with reduced immunologic side effects
11/04/2004	US20040217055 purified; fatty acids removed; efficiency, low cost
11/04/2004	DE10318048A1 Nicht fluoreszierende, durch Proteolyse zur Fluoreszenz aktivierbare Reporterproteine und ihre Verwendung zur Detektion Protease-abhängiger Ereignisse Non-fluorescent, to be activated by proteolysis fluorescent reporter proteins and their use for the detection of protease-dependent events
11/04/2004	DE10316701A1 New nucleic acid, and derived proteins, useful for diagnosis of bronchial cancer and in screening for therapeutic and diagnostic agents
11/04/2004	DE10316059A1 Diagnosis, prognosis and monitoring of cardiovascular disease, by determining at least one of soluble CD40 ligand, pregnancy-associated plasma protein-A or placental growth factor
11/04/2004	CA2526915A1 Methods of treating diseases responsive to induction of apoptosis and screening assays
11/04/2004	CA2526914A1 Compositions and methods relating to stop-1
11/04/2004	CA2526887A1 Splice variants of human voltage-gated calcium channel alpha2delta-2 subunit designated-alpha2delta2-a and alpha2delta2-b
11/04/2004	CA2523459A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	CA2523452A1 Cancer specific monoclonal antibodies
11/04/2004	CA2523358A1 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections
11/04/2004	CA2523197A1 Peptide vectors
11/04/2004	CA2522904A1 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	CA2522819A1 Polyvalent protein complex
11/04/2004	CA2522815A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases
11/04/2004	CA2522758A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
11/04/2004	CA2522751A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/04/2004	CA2522718A1 A novel method of modulating bone-related activity
11/04/2004	CA2522703A1 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	CA2522497A1 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	CA2522400A1 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
11/04/2004	CA2522364A1 Polymer-conjugated glycosylated neublastin
11/04/2004	CA2522362A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	CA2522359A1 Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions
11/04/2004	CA2522184A1 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	CA2522172A1 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	CA2522081A1 Recombinant influenza viruses holding a mutation in a transmembrane protein gene
11/04/2004	CA2520424A1 Model for neurodegenerative disorders
11/04/2004	CA2520097A1 Truncated baff receptors
11/04/2004	CA2518336A1 Polyethelene glycol link glp-1 compounds
11/04/2004	CA2517134A1 Methods for obtaining colonization factors from bacterial strains
11/03/2004	EP1473369A2 Compositions and methods for delivery of genetic material
11/03/2004	EP1473367A1 Means and methods for diagnosing and treating affective disorders

1 ... 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 ... 2916